Loading…
Reported covered position: Chief of Staff, Leg. Director, & Staff Assist. to Sen. Chris Dodd, and Prof. Staff Member of Senate HELP Subcommittee on Children & Families, Chaired by Sen. Dodd (1996-2011)
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
FAST Generics Act of 2017
Client: TEVA PHARMACEUTICALS USA INC · Firm: TEVA PHARMACEUTICALS USA, INC.
Medicaid Rebate provision of the Bipartisan Budget Act of 2015; the Creating & Restoring Equal Access to Equivalent Samples Act ("CREATES Act"); HR 2051-FAST Generics Act; S.771-Improving Access to Affordable Drugs Act; HR 749-Lower Drugs Through Competition Act; and Administration review of drug pricing policies.
FAST Generics Act of 2017
Client: TEVA PHARMACEUTICALS USA INC · Firm: TEVA PHARMACEUTICALS USA, INC.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
TEVA PHARMACEUTICALS USA INC via TEVA PHARMACEUTICALS USA, INC.
2018 · fourth_quarter · Q4
Medicaid Rebate provision of the Bipartisan Budget Act of 2015; the Creating & Restoring Equal Access to Equivalent Samples Act ("CREATES Act"); HR 2051-FAST Generics Act; S.771-Improving Access to Affordable Drugs Act; HR 749-Lower Drugs Through Competition Act; and Administration review of drug pricing policies.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Source: Senate LDA
Medicaid Rebate provision of the Bipartisan Budget Act of 2015; draft of the Creating & Restoring Equal Access to Equivalent Samples Act ("CREATES Act"; HR 2051-FAST Generics Act; S.771-Improving Access to Affordable Drugs Act; HR 749-Lower Drugs Through Competition Act; Administration review of drug pricing policies; and proposals relating to drug importation policy.
FAST Generics Act of 2017
Client: TEVA PHARMACEUTICALS USA INC · Firm: TEVA PHARMACEUTICALS USA, INC.
Medicaid Rebate provision of the Bipartisan Budget Act of 2015; draft of the Creating & Restoring Equal Access to Equivalent Samples Act ("CREATES Act"; HR 2051-FAST Generics Act; S.771-Improving Access to Affordable Drugs Act; HR 749-Lower Drugs Through Competition Act; and Administration review of drug pricing policies.
FAST Generics Act of 2017
Client: TEVA PHARMACEUTICALS USA INC · Firm: TEVA PHARMACEUTICALS USA, INC.
Medicaid Rebate provision of the Bipartisan Budget Act of 2015; draft of the Creating & Restoring Equal Access to Equivalent Samples Act ("CREATES Act") for 2017; HR 2051-FAST Generics Act; S.771-Improving Access to Affordable Drugs Act; S.469-Affordable and Safe Prescription Drug Importation Act; HR 749-Lower Drugs Through Competition Act; and Consolidated Appropriations Act of 2018 (provisions relating to Medicare and patent settlements.
FAST Generics Act of 2017
Client: TEVA PHARMACEUTICALS USA INC · Firm: TEVA PHARMACEUTICALS USA, INC.
Medicaid Rebate provision of the Bipartisan Budget Act of 2015; draft of the Creating & Restoring Equal Access to Equivalent Samples Act ("CREATES Act"; HR 2051-FAST Generics Act; S.771-Improving Access to Affordable Drugs Act; HR 749-Lower Drugs Through Competition Act; Administration review of drug pricing policies; and proposals relating to drug importation policy.
Lower Drug Costs through Competition Act
Client: TEVA PHARMACEUTICALS USA INC · Firm: TEVA PHARMACEUTICALS USA, INC.
Medicaid Rebate provision of the Bipartisan Budget Act of 2015; draft of the Creating & Restoring Equal Access to Equivalent Samples Act ("CREATES Act"; HR 2051-FAST Generics Act; S.771-Improving Access to Affordable Drugs Act; HR 749-Lower Drugs Through Competition Act; Administration review of drug pricing policies; and proposals relating to drug importation policy.
Lower Drug Costs through Competition Act
Client: TEVA PHARMACEUTICALS USA INC · Firm: TEVA PHARMACEUTICALS USA, INC.
Medicaid Rebate provision of the Bipartisan Budget Act of 2015; the Creating & Restoring Equal Access to Equivalent Samples Act ("CREATES Act"); HR 2051-FAST Generics Act; S.771-Improving Access to Affordable Drugs Act; HR 749-Lower Drugs Through Competition Act; and Administration review of drug pricing policies.
Lower Drug Costs through Competition Act
Client: TEVA PHARMACEUTICALS USA INC · Firm: TEVA PHARMACEUTICALS USA, INC.
Medicaid Rebate provision of the Bipartisan Budget Act of 2015; draft of the Creating & Restoring Equal Access to Equivalent Samples Act ("CREATES Act"; HR 2051-FAST Generics Act; S.771-Improving Access to Affordable Drugs Act; HR 749-Lower Drugs Through Competition Act; Administration review of drug pricing policies; and proposals relating to drug importation policy.
Lower Drug Costs through Competition Act
Client: TEVA PHARMACEUTICALS USA INC · Firm: TEVA PHARMACEUTICALS USA, INC.
Medicaid Rebate provision of the Bipartisan Budget Act of 2015; draft of the Creating & Restoring Equal Access to Equivalent Samples Act ("CREATES Act"; HR 2051-FAST Generics Act; S.771-Improving Access to Affordable Drugs Act; HR 749-Lower Drugs Through Competition Act; and Administration review of drug pricing policies.
Lower Drug Costs through Competition Act
Client: TEVA PHARMACEUTICALS USA INC · Firm: TEVA PHARMACEUTICALS USA, INC.
Medicaid Rebate provision of the Bipartisan Budget Act of 2015; draft of the Creating & Restoring Equal Access to Equivalent Samples Act ("CREATES Act") for 2017; HR 2051-FAST Generics Act; S.771-Improving Access to Affordable Drugs Act; S.469-Affordable and Safe Prescription Drug Importation Act; HR 749-Lower Drugs Through Competition Act; and Consolidated Appropriations Act of 2018 (provisions relating to Medicare and patent settlements.
Affordable and Safe Prescription Drug Importation Act
Client: TEVA PHARMACEUTICALS USA INC · Firm: TEVA PHARMACEUTICALS USA, INC.
Medicaid Rebate provision of the Bipartisan Budget Act of 2015; draft of the Creating & Restoring Equal Access to Equivalent Samples Act ("CREATES Act") for 2017; HR 2051-FAST Generics Act; S.771-Improving Access to Affordable Drugs Act; S.469-Affordable and Safe Prescription Drug Importation Act; HR 749-Lower Drugs Through Competition Act; and Consolidated Appropriations Act of 2018 (provisions relating to Medicare and patent settlements.
Improving Access To Affordable Prescription Drugs Act
Client: TEVA PHARMACEUTICALS USA INC · Firm: TEVA PHARMACEUTICALS USA, INC.
Medicaid Rebate provision of the Bipartisan Budget Act of 2015; draft of the Creating & Restoring Equal Access to Equivalent Samples Act ("CREATES Act"; HR 2051-FAST Generics Act; S.771-Improving Access to Affordable Drugs Act; HR 749-Lower Drugs Through Competition Act; Administration review of drug pricing policies; and proposals relating to drug importation policy.
Improving Access To Affordable Prescription Drugs Act
Client: TEVA PHARMACEUTICALS USA INC · Firm: TEVA PHARMACEUTICALS USA, INC.
Medicaid Rebate provision of the Bipartisan Budget Act of 2015; draft of the Creating & Restoring Equal Access to Equivalent Samples Act ("CREATES Act"; HR 2051-FAST Generics Act; S.771-Improving Access to Affordable Drugs Act; HR 749-Lower Drugs Through Competition Act; Administration review of drug pricing policies; and proposals relating to drug importation policy.
Improving Access To Affordable Prescription Drugs Act
Client: TEVA PHARMACEUTICALS USA INC · Firm: TEVA PHARMACEUTICALS USA, INC.
Medicaid Rebate provision of the Bipartisan Budget Act of 2015; draft of the Creating & Restoring Equal Access to Equivalent Samples Act ("CREATES Act"; HR 2051-FAST Generics Act; S.771-Improving Access to Affordable Drugs Act; HR 749-Lower Drugs Through Competition Act; and Administration review of drug pricing policies.
Improving Access To Affordable Prescription Drugs Act
Client: TEVA PHARMACEUTICALS USA INC · Firm: TEVA PHARMACEUTICALS USA, INC.
Medicaid Rebate provision of the Bipartisan Budget Act of 2015; draft of the Creating & Restoring Equal Access to Equivalent Samples Act ("CREATES Act") for 2017; HR 2051-FAST Generics Act; S.771-Improving Access to Affordable Drugs Act; S.469-Affordable and Safe Prescription Drug Importation Act; HR 749-Lower Drugs Through Competition Act; and Consolidated Appropriations Act of 2018 (provisions relating to Medicare and patent settlements.
Improving Access To Affordable Prescription Drugs Act
Client: TEVA PHARMACEUTICALS USA INC · Firm: TEVA PHARMACEUTICALS USA, INC.
Medicaid Rebate provision of the Bipartisan Budget Act of 2015; the Creating & Restoring Equal Access to Equivalent Samples Act ("CREATES Act"); HR 2051-FAST Generics Act; S.771-Improving Access to Affordable Drugs Act; HR 749-Lower Drugs Through Competition Act; and Administration review of drug pricing policies.
American Health Care Act of 2017
Client: TEVA PHARMACEUTICALS USA INC · Firm: TEVA PHARMACEUTICALS USA, INC.
HR 1628-American Health Care Act; Medicaid Rebate provision of the Bipartisan Budget Act of 2015; draft of the Creating & Restoring Equal Access to Equivalent Samples Act ("CREATES Act") for 2017; HR 2051-FAST Generics Act; S.637-C-THRU Act; S.771-Improving Access to Affordable Drugs Act; Importation Amdt. to Senate Budget Resolution; S.469-Affordable and Safe Prescription Drug Importation Act; HR 749-Lower Drugs Through Competition Act; and FDA Reauthorization Act of 2017.
FAST Generics Act of 2017
Client: TEVA PHARMACEUTICALS USA INC · Firm: TEVA PHARMACEUTICALS USA, INC.
HR 1628-American Health Care Act; Medicaid Rebate provision of the Bipartisan Budget Act of 2015; draft of the Creating & Restoring Equal Access to Equivalent Samples Act ("CREATES Act") for 2017; HR 2051-FAST Generics Act; S.637-C-THRU Act; S.771-Improving Access to Affordable Drugs Act; Importation Amdt. to Senate Budget Resolution; S.469-Affordable and Safe Prescription Drug Importation Act; HR 749-Lower Drugs Through Competition Act; and FDA Reauthorization Act of 2017.
Lower Drug Costs through Competition Act
Client: TEVA PHARMACEUTICALS USA INC · Firm: TEVA PHARMACEUTICALS USA, INC.
HR 1628-American Health Care Act; Medicaid Rebate provision of the Bipartisan Budget Act of 2015; draft of the Creating & Restoring Equal Access to Equivalent Samples Act ("CREATES Act") for 2017; HR 2051-FAST Generics Act; S.637-C-THRU Act; S.771-Improving Access to Affordable Drugs Act; Importation Amdt. to Senate Budget Resolution; S.469-Affordable and Safe Prescription Drug Importation Act; HR 749-Lower Drugs Through Competition Act; and FDA Reauthorization Act of 2017.
Affordable and Safe Prescription Drug Importation Act
Client: TEVA PHARMACEUTICALS USA INC · Firm: TEVA PHARMACEUTICALS USA, INC.
HR 1628-American Health Care Act; Medicaid Rebate provision of the Bipartisan Budget Act of 2015; draft of the Creating & Restoring Equal Access to Equivalent Samples Act ("CREATES Act") for 2017; HR 2051-FAST Generics Act; S.637-C-THRU Act; S.771-Improving Access to Affordable Drugs Act; Importation Amdt. to Senate Budget Resolution; S.469-Affordable and Safe Prescription Drug Importation Act; HR 749-Lower Drugs Through Competition Act; and FDA Reauthorization Act of 2017.
Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act of 2017
Client: TEVA PHARMACEUTICALS USA INC · Firm: TEVA PHARMACEUTICALS USA, INC.
HR 1628-American Health Care Act; Medicaid Rebate provision of the Bipartisan Budget Act of 2015; draft of the Creating & Restoring Equal Access to Equivalent Samples Act ("CREATES Act") for 2017; HR 2051-FAST Generics Act; S.637-C-THRU Act; S.771-Improving Access to Affordable Drugs Act; Importation Amdt. to Senate Budget Resolution; S.469-Affordable and Safe Prescription Drug Importation Act; HR 749-Lower Drugs Through Competition Act; and FDA Reauthorization Act of 2017.
Improving Access To Affordable Prescription Drugs Act
Client: TEVA PHARMACEUTICALS USA INC · Firm: TEVA PHARMACEUTICALS USA, INC.
HR 1628-American Health Care Act; Medicaid Rebate provision of the Bipartisan Budget Act of 2015; draft of the Creating & Restoring Equal Access to Equivalent Samples Act ("CREATES Act") for 2017; HR 2051-FAST Generics Act; S.637-C-THRU Act; S.771-Improving Access to Affordable Drugs Act; Importation Amdt. to Senate Budget Resolution; S.469-Affordable and Safe Prescription Drug Importation Act; HR 749-Lower Drugs Through Competition Act; and FDA Reauthorization Act of 2017.
2018 · third_quarter · Q3
Medicaid Rebate provision of the Bipartisan Budget Act of 2015; draft of the Creating & Restoring Equal Access to Equivalent Samples Act ("CREATES Act"; HR 2051-FAST Generics Act; S.771-Improving Access to Affordable Drugs Act; HR 749-Lower Drugs Through Competition Act; and Administration review of drug pricing policies.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
TEVA PHARMACEUTICALS USA INC via TEVA PHARMACEUTICALS USA, INC.
2018 · second_quarter · 2A
Medicaid Rebate provision of the Bipartisan Budget Act of 2015; draft of the Creating & Restoring Equal Access to Equivalent Samples Act ("CREATES Act"; HR 2051-FAST Generics Act; S.771-Improving Access to Affordable Drugs Act; HR 749-Lower Drugs Through Competition Act; Administration review of drug pricing policies; and proposals relating to drug importation policy.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
TEVA PHARMACEUTICALS USA INC via TEVA PHARMACEUTICALS USA, INC.
2018 · second_quarter · Q2
Medicaid Rebate provision of the Bipartisan Budget Act of 2015; draft of the Creating & Restoring Equal Access to Equivalent Samples Act ("CREATES Act"; HR 2051-FAST Generics Act; S.771-Improving Access to Affordable Drugs Act; HR 749-Lower Drugs Through Competition Act; Administration review of drug pricing policies; and proposals relating to drug importation policy.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
TEVA PHARMACEUTICALS USA INC via TEVA PHARMACEUTICALS USA, INC.
2018 · first_quarter · Q1
Medicaid Rebate provision of the Bipartisan Budget Act of 2015; draft of the Creating & Restoring Equal Access to Equivalent Samples Act ("CREATES Act") for 2017; HR 2051-FAST Generics Act; S.771-Improving Access to Affordable Drugs Act; S.469-Affordable and Safe Prescription Drug Importation Act; HR 749-Lower Drugs Through Competition Act; and Consolidated Appropriations Act of 2018 (provisions relating to Medicare and patent settlements.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TEVA PHARMACEUTICALS USA INC via TEVA PHARMACEUTICALS USA, INC.
2017 · fourth_quarter · Q4
HR 1628-American Health Care Act; Medicaid Rebate provision of the Bipartisan Budget Act of 2015; draft of the Creating & Restoring Equal Access to Equivalent Samples Act ("CREATES Act") for 2017; HR 2051-FAST Generics Act; S.637-C-THRU Act; S.771-Improving Access to Affordable Drugs Act; Importation Amdt. to Senate Budget Resolution; S.469-Affordable and Safe Prescription Drug Importation Act; HR 749-Lower Drugs Through Competition Act; and FDA Reauthorization Act of 2017.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office